The global market for Leucocyte-Stimulating Biologics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Leucocyte-Stimulating Biologics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Leucocyte-Stimulating Biologics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Leucocyte-Stimulating Biologics in Neoplastic Diseases is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Leucocyte-Stimulating Biologics include Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., Coherus BioSciences, Inc., Teva Pharmaceutical, Sanofi, Yifan Pharmaceutical, CSPC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Leucocyte-Stimulating Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leucocyte-Stimulating Biologics.

The Leucocyte-Stimulating Biologics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Leucocyte-Stimulating Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Leucocyte-Stimulating Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Leucocyte-Stimulating Biologics Market Report

Report Metric	Details
Report Name	Leucocyte-Stimulating Biologics Market
Segment by Type	Long-acting Short-acting
Segment by Application	Neoplastic Diseases Blood Disorders Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., Coherus BioSciences, Inc., Teva Pharmaceutical, Sanofi, Yifan Pharmaceutical, CSPC, Jiangsu Hengrui Medicine, Qilu Pharmaceutical, Shan Dong Kexing Biopharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leucocyte-Stimulating Biologics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Leucocyte-Stimulating Biologics Market report?

Ans: The main players in the Leucocyte-Stimulating Biologics Market are Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., Coherus BioSciences, Inc., Teva Pharmaceutical, Sanofi, Yifan Pharmaceutical, CSPC, Jiangsu Hengrui Medicine, Qilu Pharmaceutical, Shan Dong Kexing Biopharm

What are the Application segmentation covered in the Leucocyte-Stimulating Biologics Market report?

Ans: The Applications covered in the Leucocyte-Stimulating Biologics Market report are Neoplastic Diseases, Blood Disorders, Others

What are the Type segmentation covered in the Leucocyte-Stimulating Biologics Market report?

Ans: The Types covered in the Leucocyte-Stimulating Biologics Market report are Long-acting, Short-acting

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Leucocyte-Stimulating Biologics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Long-acting

1.2.3 Short-acting

1.3 Market by Application

1.3.1 Global Leucocyte-Stimulating Biologics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Neoplastic Diseases

1.3.3 Blood Disorders

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Leucocyte-Stimulating Biologics Market Perspective (2020-2031)

2.2 Global Leucocyte-Stimulating Biologics Growth Trends by Region

2.2.1 Global Leucocyte-Stimulating Biologics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Leucocyte-Stimulating Biologics Historic Market Size by Region (2020-2025)

2.2.3 Leucocyte-Stimulating Biologics Forecasted Market Size by Region (2026-2031)

2.3 Leucocyte-Stimulating Biologics Market Dynamics

2.3.1 Leucocyte-Stimulating Biologics Industry Trends

2.3.2 Leucocyte-Stimulating Biologics Market Drivers

2.3.3 Leucocyte-Stimulating Biologics Market Challenges

2.3.4 Leucocyte-Stimulating Biologics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Leucocyte-Stimulating Biologics Players by Revenue

3.1.1 Global Top Leucocyte-Stimulating Biologics Players by Revenue (2020-2025)

3.1.2 Global Leucocyte-Stimulating Biologics Revenue Market Share by Players (2020-2025)

3.2 Global Leucocyte-Stimulating Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Leucocyte-Stimulating Biologics Revenue

3.4 Global Leucocyte-Stimulating Biologics Market Concentration Ratio

3.4.1 Global Leucocyte-Stimulating Biologics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Leucocyte-Stimulating Biologics Revenue in 2024

3.5 Global Key Players of Leucocyte-Stimulating Biologics Head office and Area Served

3.6 Global Key Players of Leucocyte-Stimulating Biologics, Product and Application

3.7 Global Key Players of Leucocyte-Stimulating Biologics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Leucocyte-Stimulating Biologics Breakdown Data by Type

4.1 Global Leucocyte-Stimulating Biologics Historic Market Size by Type (2020-2025)

4.2 Global Leucocyte-Stimulating Biologics Forecasted Market Size by Type (2026-2031)

5 Leucocyte-Stimulating Biologics Breakdown Data by Application

5.1 Global Leucocyte-Stimulating Biologics Historic Market Size by Application (2020-2025)

5.2 Global Leucocyte-Stimulating Biologics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Leucocyte-Stimulating Biologics Market Size (2020-2031)

6.2 North America Leucocyte-Stimulating Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Leucocyte-Stimulating Biologics Market Size by Country (2020-2025)

6.4 North America Leucocyte-Stimulating Biologics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Leucocyte-Stimulating Biologics Market Size (2020-2031)

7.2 Europe Leucocyte-Stimulating Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Leucocyte-Stimulating Biologics Market Size by Country (2020-2025)

7.4 Europe Leucocyte-Stimulating Biologics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Leucocyte-Stimulating Biologics Market Size (2020-2031)

8.2 Asia-Pacific Leucocyte-Stimulating Biologics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Leucocyte-Stimulating Biologics Market Size by Region (2020-2025)

8.4 Asia-Pacific Leucocyte-Stimulating Biologics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Leucocyte-Stimulating Biologics Market Size (2020-2031)

9.2 Latin America Leucocyte-Stimulating Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Leucocyte-Stimulating Biologics Market Size by Country (2020-2025)

9.4 Latin America Leucocyte-Stimulating Biologics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Leucocyte-Stimulating Biologics Market Size (2020-2031)

10.2 Middle East & Africa Leucocyte-Stimulating Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Leucocyte-Stimulating Biologics Market Size by Country (2020-2025)

10.4 Middle East & Africa Leucocyte-Stimulating Biologics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen Inc.

11.1.1 Amgen Inc. Company Details

11.1.2 Amgen Inc. Business Overview

11.1.3 Amgen Inc. Leucocyte-Stimulating Biologics Introduction

11.1.4 Amgen Inc. Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.1.5 Amgen Inc. Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Leucocyte-Stimulating Biologics Introduction

11.2.4 Pfizer Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Sandoz (Novartis)

11.3.1 Sandoz (Novartis) Company Details

11.3.2 Sandoz (Novartis) Business Overview

11.3.3 Sandoz (Novartis) Leucocyte-Stimulating Biologics Introduction

11.3.4 Sandoz (Novartis) Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.3.5 Sandoz (Novartis) Recent Development

11.4 Spectrum Pharmaceuticals

11.4.1 Spectrum Pharmaceuticals Company Details

11.4.2 Spectrum Pharmaceuticals Business Overview

11.4.3 Spectrum Pharmaceuticals Leucocyte-Stimulating Biologics Introduction

11.4.4 Spectrum Pharmaceuticals Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.4.5 Spectrum Pharmaceuticals Recent Development

11.5 Biocon Biologics Inc.

11.5.1 Biocon Biologics Inc. Company Details

11.5.2 Biocon Biologics Inc. Business Overview

11.5.3 Biocon Biologics Inc. Leucocyte-Stimulating Biologics Introduction

11.5.4 Biocon Biologics Inc. Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.5.5 Biocon Biologics Inc. Recent Development

11.6 Coherus BioSciences, Inc.

11.6.1 Coherus BioSciences, Inc. Company Details

11.6.2 Coherus BioSciences, Inc. Business Overview

11.6.3 Coherus BioSciences, Inc. Leucocyte-Stimulating Biologics Introduction

11.6.4 Coherus BioSciences, Inc. Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.6.5 Coherus BioSciences, Inc. Recent Development

11.7 Teva Pharmaceutical

11.7.1 Teva Pharmaceutical Company Details

11.7.2 Teva Pharmaceutical Business Overview

11.7.3 Teva Pharmaceutical Leucocyte-Stimulating Biologics Introduction

11.7.4 Teva Pharmaceutical Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.7.5 Teva Pharmaceutical Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Leucocyte-Stimulating Biologics Introduction

11.8.4 Sanofi Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.8.5 Sanofi Recent Development

11.9 Yifan Pharmaceutical

11.9.1 Yifan Pharmaceutical Company Details

11.9.2 Yifan Pharmaceutical Business Overview

11.9.3 Yifan Pharmaceutical Leucocyte-Stimulating Biologics Introduction

11.9.4 Yifan Pharmaceutical Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.9.5 Yifan Pharmaceutical Recent Development

11.10 CSPC

11.10.1 CSPC Company Details

11.10.2 CSPC Business Overview

11.10.3 CSPC Leucocyte-Stimulating Biologics Introduction

11.10.4 CSPC Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.10.5 CSPC Recent Development

11.11 Jiangsu Hengrui Medicine

11.11.1 Jiangsu Hengrui Medicine Company Details

11.11.2 Jiangsu Hengrui Medicine Business Overview

11.11.3 Jiangsu Hengrui Medicine Leucocyte-Stimulating Biologics Introduction

11.11.4 Jiangsu Hengrui Medicine Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.11.5 Jiangsu Hengrui Medicine Recent Development

11.12 Qilu Pharmaceutical

11.12.1 Qilu Pharmaceutical Company Details

11.12.2 Qilu Pharmaceutical Business Overview

11.12.3 Qilu Pharmaceutical Leucocyte-Stimulating Biologics Introduction

11.12.4 Qilu Pharmaceutical Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.12.5 Qilu Pharmaceutical Recent Development

11.13 Shan Dong Kexing Biopharm

11.13.1 Shan Dong Kexing Biopharm Company Details

11.13.2 Shan Dong Kexing Biopharm Business Overview

11.13.3 Shan Dong Kexing Biopharm Leucocyte-Stimulating Biologics Introduction

11.13.4 Shan Dong Kexing Biopharm Revenue in Leucocyte-Stimulating Biologics Business (2020-2025)

11.13.5 Shan Dong Kexing Biopharm Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Sandoz(Novartis)

Spectrum Pharmaceuticals

Biocon Biologics Inc

Yifan Pharmaceutical

CSPC

Jiangsu Hengrui Medicine

Qilu Pharmaceutical

Shan Dong Kexing Biopharm

List of Tables

Table 1. Global Leucocyte-Stimulating Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Long-acting

Table 3. Key Players of Short-acting

Table 4. Global Leucocyte-Stimulating Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Leucocyte-Stimulating Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Leucocyte-Stimulating Biologics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Leucocyte-Stimulating Biologics Market Share by Region (2020-2025)

Table 8. Global Leucocyte-Stimulating Biologics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Leucocyte-Stimulating Biologics Market Share by Region (2026-2031)

Table 10. Leucocyte-Stimulating Biologics Market Trends

Table 11. Leucocyte-Stimulating Biologics Market Drivers

Table 12. Leucocyte-Stimulating Biologics Market Challenges

Table 13. Leucocyte-Stimulating Biologics Market Restraints

Table 14. Global Leucocyte-Stimulating Biologics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Leucocyte-Stimulating Biologics Market Share by Players (2020-2025)

Table 16. Global Top Leucocyte-Stimulating Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leucocyte-Stimulating Biologics as of 2024)

Table 17. Ranking of Global Top Leucocyte-Stimulating Biologics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Leucocyte-Stimulating Biologics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Leucocyte-Stimulating Biologics, Headquarters and Area Served

Table 20. Global Key Players of Leucocyte-Stimulating Biologics, Product and Application

Table 21. Global Key Players of Leucocyte-Stimulating Biologics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Leucocyte-Stimulating Biologics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Leucocyte-Stimulating Biologics Revenue Market Share by Type (2020-2025)

Table 25. Global Leucocyte-Stimulating Biologics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Leucocyte-Stimulating Biologics Revenue Market Share by Type (2026-2031)

Table 27. Global Leucocyte-Stimulating Biologics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Leucocyte-Stimulating Biologics Revenue Market Share by Application (2020-2025)

Table 29. Global Leucocyte-Stimulating Biologics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Leucocyte-Stimulating Biologics Revenue Market Share by Application (2026-2031)

Table 31. North America Leucocyte-Stimulating Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Leucocyte-Stimulating Biologics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Leucocyte-Stimulating Biologics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Leucocyte-Stimulating Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Leucocyte-Stimulating Biologics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Leucocyte-Stimulating Biologics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Leucocyte-Stimulating Biologics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Leucocyte-Stimulating Biologics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Leucocyte-Stimulating Biologics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Leucocyte-Stimulating Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Leucocyte-Stimulating Biologics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Leucocyte-Stimulating Biologics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Leucocyte-Stimulating Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Leucocyte-Stimulating Biologics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Leucocyte-Stimulating Biologics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Amgen Inc. Company Details

Table 47. Amgen Inc. Business Overview

Table 48. Amgen Inc. Leucocyte-Stimulating Biologics Product

Table 49. Amgen Inc. Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 50. Amgen Inc. Recent Development

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer Leucocyte-Stimulating Biologics Product

Table 54. Pfizer Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. Sandoz (Novartis) Company Details

Table 57. Sandoz (Novartis) Business Overview

Table 58. Sandoz (Novartis) Leucocyte-Stimulating Biologics Product

Table 59. Sandoz (Novartis) Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 60. Sandoz (Novartis) Recent Development

Table 61. Spectrum Pharmaceuticals Company Details

Table 62. Spectrum Pharmaceuticals Business Overview

Table 63. Spectrum Pharmaceuticals Leucocyte-Stimulating Biologics Product

Table 64. Spectrum Pharmaceuticals Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 65. Spectrum Pharmaceuticals Recent Development

Table 66. Biocon Biologics Inc. Company Details

Table 67. Biocon Biologics Inc. Business Overview

Table 68. Biocon Biologics Inc. Leucocyte-Stimulating Biologics Product

Table 69. Biocon Biologics Inc. Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 70. Biocon Biologics Inc. Recent Development

Table 71. Coherus BioSciences, Inc. Company Details

Table 72. Coherus BioSciences, Inc. Business Overview

Table 73. Coherus BioSciences, Inc. Leucocyte-Stimulating Biologics Product

Table 74. Coherus BioSciences, Inc. Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 75. Coherus BioSciences, Inc. Recent Development

Table 76. Teva Pharmaceutical Company Details

Table 77. Teva Pharmaceutical Business Overview

Table 78. Teva Pharmaceutical Leucocyte-Stimulating Biologics Product

Table 79. Teva Pharmaceutical Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 80. Teva Pharmaceutical Recent Development

Table 81. Sanofi Company Details

Table 82. Sanofi Business Overview

Table 83. Sanofi Leucocyte-Stimulating Biologics Product

Table 84. Sanofi Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 85. Sanofi Recent Development

Table 86. Yifan Pharmaceutical Company Details

Table 87. Yifan Pharmaceutical Business Overview

Table 88. Yifan Pharmaceutical Leucocyte-Stimulating Biologics Product

Table 89. Yifan Pharmaceutical Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 90. Yifan Pharmaceutical Recent Development

Table 91. CSPC Company Details

Table 92. CSPC Business Overview

Table 93. CSPC Leucocyte-Stimulating Biologics Product

Table 94. CSPC Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 95. CSPC Recent Development

Table 96. Jiangsu Hengrui Medicine Company Details

Table 97. Jiangsu Hengrui Medicine Business Overview

Table 98. Jiangsu Hengrui Medicine Leucocyte-Stimulating Biologics Product

Table 99. Jiangsu Hengrui Medicine Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 100. Jiangsu Hengrui Medicine Recent Development

Table 101. Qilu Pharmaceutical Company Details

Table 102. Qilu Pharmaceutical Business Overview

Table 103. Qilu Pharmaceutical Leucocyte-Stimulating Biologics Product

Table 104. Qilu Pharmaceutical Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 105. Qilu Pharmaceutical Recent Development

Table 106. Shan Dong Kexing Biopharm Company Details

Table 107. Shan Dong Kexing Biopharm Business Overview

Table 108. Shan Dong Kexing Biopharm Leucocyte-Stimulating Biologics Product

Table 109. Shan Dong Kexing Biopharm Revenue in Leucocyte-Stimulating Biologics Business (2020-2025) & (US$ Million)

Table 110. Shan Dong Kexing Biopharm Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Leucocyte-Stimulating Biologics Picture

Figure 2. Global Leucocyte-Stimulating Biologics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Leucocyte-Stimulating Biologics Market Share by Type: 2024 VS 2031

Figure 4. Long-acting Features

Figure 5. Short-acting Features

Figure 6. Global Leucocyte-Stimulating Biologics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Leucocyte-Stimulating Biologics Market Share by Application: 2024 VS 2031

Figure 8. Neoplastic Diseases Case Studies

Figure 9. Blood Disorders Case Studies

Figure 10. Others Case Studies

Figure 11. Leucocyte-Stimulating Biologics Report Years Considered

Figure 12. Global Leucocyte-Stimulating Biologics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Leucocyte-Stimulating Biologics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Leucocyte-Stimulating Biologics Market Share by Region: 2024 VS 2031

Figure 15. Global Leucocyte-Stimulating Biologics Market Share by Players in 2024

Figure 16. Global Top Leucocyte-Stimulating Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leucocyte-Stimulating Biologics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Leucocyte-Stimulating Biologics Revenue in 2024

Figure 18. North America Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Leucocyte-Stimulating Biologics Market Share by Country (2020-2031)

Figure 20. United States Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Leucocyte-Stimulating Biologics Market Share by Country (2020-2031)

Figure 24. Germany Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Leucocyte-Stimulating Biologics Market Share by Region (2020-2031)

Figure 32. China Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Leucocyte-Stimulating Biologics Market Share by Country (2020-2031)

Figure 40. Mexico Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Leucocyte-Stimulating Biologics Market Share by Country (2020-2031)

Figure 44. Turkey Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Leucocyte-Stimulating Biologics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Amgen Inc. Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 48. Pfizer Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 49. Sandoz (Novartis) Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 50. Spectrum Pharmaceuticals Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 51. Biocon Biologics Inc. Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 52. Coherus BioSciences, Inc. Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 53. Teva Pharmaceutical Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 54. Sanofi Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 55. Yifan Pharmaceutical Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 56. CSPC Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 57. Jiangsu Hengrui Medicine Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 58. Qilu Pharmaceutical Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 59. Shan Dong Kexing Biopharm Revenue Growth Rate in Leucocyte-Stimulating Biologics Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions